Skip to main content

Advertisement

Table 3 Platelet reactivity and clopidogrel resistance in patients with and without diabetes mellitus

From: Effects of Ramadan fasting on platelet reactivity in diabetic patients treated with clopidogrel

  All DM Non DM
n = 98 n = 63 n = 35
Pre-Ramadan
 PRU median (IQR) 199 (157–251) 200 (157–253) 196 (157–248)
 Clopidogrel resistance n (%)
  PRU > 235 36 (36.7) 23 (36.5) 13 (37.1)
  PRU > 208 48 (48.9) 33 (52.3) 15 (42.8)
Ramadan
 PRU median (IQR) 212 (169–257) 227 (176–261)* 200 (159–252) £
 Clopidogrel resistance n (%)
  PRU > 235 39 (39.7) 27 (42.8) 12 (34.2)
  PRU > 208 54 (55.1) 38 (60.3) 16 (45.7)
Post-R (n = 109)
 PRU median (IQR) 210 (166–251) 216 (176–247)* 202 (153–254)
 Clopidogrel resistance n (%)
  PRU > 235 39 (39.7) 23 (36.5) 16 (45.7)
  PRU > 208 52 (53.0) 35 (55.5) 17 (48.5)
  1. DM diabetes mellitus
  2. * p < 0.05 compared to Pre-Ramadan.
  3. £ p < 0.05 compared to patients with DM